Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.

about

The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response.Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.

P2860

Q48154938-3FE89D92-E37F-4C78-9DB6-83C52DA1AD2D Q50224356-2E6AB4B7-4C8B-4567-AA34-DEB0EA0570C9

P2860

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.

Item

http://www.wikidata.org/entity/Q48236916

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Heavy/light chain ratio for th ...... s achieving complete response.

@en

Heavy/light chain ratio for th ...... s achieving complete response.

@nl

type

Item

label

Heavy/light chain ratio for th ...... s achieving complete response.

@en

Heavy/light chain ratio for th ...... s achieving complete response.

@nl

prefLabel

Heavy/light chain ratio for th ...... s achieving complete response.

@en

Heavy/light chain ratio for th ...... s achieving complete response.

@nl

P1476

Heavy/light chain ratio for th ...... s achieving complete response.

@en

P2093

Antonio Traficante

http://www.w3.org/2001/XMLSchema#string

Giovanna Mansueto

http://www.w3.org/2001/XMLSchema#string

Giovanni D'Arena

http://www.w3.org/2001/XMLSchema#string

Giuseppe Pietrantuono

http://www.w3.org/2001/XMLSchema#string

Oreste Villani

http://www.w3.org/2001/XMLSchema#string

Teodora Statuto

http://www.w3.org/2001/XMLSchema#string

Vittorio Simeon

http://www.w3.org/2001/XMLSchema#string

P2860

International uniform response criteria for multiple myeloma.

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.

Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.

Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.

P304

550-552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14662

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

Pellegrino Musto

Francesco La Rocca

Fiorella D'Auria

P577

2017-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28439880

http://www.w3.org/2001/XMLSchema#string

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.

about

P2860

P2860

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698